A Randomized Double-Blind Placebo-Controlled Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients with Severe Hypertriglyceridemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Hypertrygliceridemia
-
Age: Between 18 years - 99 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Participants who have severe high triglycerides
- Participants should be on standard of care (SOC) lipid-lowering medications per local guidelines
You may not be eligible for this study if the following are true:
-
- Genetically Confirmed Diagnosis of Familial Chylomicronemia Syndrome
- Prior use of investigational med or volseran
- Cancer within 5 years of Screen
- Active infection with HIV, Hepatitis B or Hepatitis C
- Pregnant or breast feeding
- Bleeding disorder
- Liver disorder
- Kidney disorder
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.